EGFR and adenocarcinoma: The histological transformation from adenocarcinoma (ADC) to squamous cell carcinoma (SCC) is rare but recurrently occurs post TKI treatment in <i>EGFR-</i>mutated non-small cell lung cancer patients with a very limited number of clinical cases published.